Neonatal acute kidney injury and the patent ductus arteriosus.

Management of Patent Ductus Arteriosus in the Adult Population.

This review covers the management of PDA in adults, highlighting the pathophysiology, morphological classification, clinical presentation, and current approaches to closure, with transcatheter closure currently the preferred approach.

Prevalence and Predictors of Patent Ductus Arteriosus on Day 3 and Day 7 in Preterm Neonates: A Prospective Observational Study

Lower gestational age and lower birth weight were significantly associated with persistence of PDA, indicating prematurity as a major determinant, highlighting PDA as a prevalent condition contributing significantly to early complications and death.

Patent Ductus Arteriosus.

Patent ductus arteriosus (PDA) is a common congenital heart defect. PDA disproportionately affects low-birth-weight infants, resulting in an incidence of 21% among preterm births as compared to 0.05% in the general population. The ductus arteriosus remains patent in the fetus, allowing maternal blood to directly enter...

Intravenous Prostaglandin E1 (Alprostadil) Bolus in Ductus Arteriosus-Dependent Congenital Heart Disease: A Case Series.

Clinical and Pathophysiological Interplay Between Patent Ductus Arteriosus and Patent Foramen Ovale: A Comparative Narrative Review

Comparisons suggest that secondary pulmonary hypertension may play an important role in this interaction between PDA and PFO, and improved understanding of this relationship may enhance diagnostic accuracy and management strategies in neonatal animals.

A narrative review of sildenafil dosing and monitoring by indication in neonatal pulmonary hypertension

Pulmonary hypertension in the neonate is a leading contributor to hypoxemic respiratory failure and carries substantial mortality across diverse etiologies, including persistent pulmonary hypertension of the newborn (PPHN), bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH), and the early postoperati...